Acarix resolves on a rights issue of approximately SEK 54 million fully guaranteed by, among others, a Danish life science fund
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...